S&P 500 Futures
(-0.08%) 5 304.25 points
Dow J Futures
(-0.09%) 40 140 points
Nasdaq Futures
(-0.05%) 18 465 points
Oil
(-0.07%) $83.11
Gas
(-0.62%) $1.752
Gold
(0.73%) $2 254.80
Silver
(0.74%) $25.10
Platinum
(0.21%) $923.00
USD/EUR
(0.13%) $0.928
USD/NOK
(0.16%) $10.86
USD/GBP
(-0.01%) $0.792
USD/RUB
(-0.34%) $92.27

Realtime updates for Lansen Pharmaceutical [0503.HK]

Exchange: HKSE Industry: Drug Manufacturers
Last Updated28 Nov 2023 @ 03:08

40.94% HKD 1.790

Live Chart Being Loaded With Signals

Commentary (28 Nov 2023 @ 03:08):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

Lansen Pharmaceutical Holdings Limited, an investment holding company, develops, produces, and sells specialty pharmaceuticals for use in the field of rheumatology and dermatology in the People's Republic of China and internationally...

Stats
Today's Volume 13.96M
Average Volume 476 561
Market Cap 750.60M
EPS HKD0 ( 2023-08-24 )
Last Dividend HKD1.497 ( 2021-09-13 )
Next Dividend HKD0 ( N/A )
P/E 13.77
ATR14 HKD0.0150 (0.84%)

Volume Correlation

Long: 0.09 (neutral)
Short: 0.00 (neutral)
Signal:(54.908) Neutral

Lansen Pharmaceutical Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Lansen Pharmaceutical Correlation - Currency/Commodity

The country flag -0.72
( moderate negative )
The country flag -0.68
( moderate negative )
The country flag 0.00
( neutral )
The country flag -0.65
( moderate negative )
The country flag 0.04
( neutral )
The country flag 0.79
( moderate )

Lansen Pharmaceutical Financials

Annual 2022
Revenue: HKD65.56M
Gross Profit: HKD44.30M (67.57 %)
EPS: HKD0.0205
Q2 2023
Revenue: HKD15.69M
Gross Profit: HKD10.27M (65.44 %)
EPS: HKD0.00660
Q1 2023
Revenue: HKD15.69M
Gross Profit: HKD10.27M (65.44 %)
EPS: HKD0.00660
Q4 2022
Revenue: HKD16.78M
Gross Profit: HKD11.18M (66.61 %)
EPS: HKD0.00210

Financial Reports:

No articles found.

Lansen Pharmaceutical Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)

Lansen Pharmaceutical Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 8.21 - good (82.09%) | Divividend Growth Potential Score: 1.655 - No dividend growth expected in the near future
Information
First Dividend HKD0.0136 2011-04-20
Last Dividend HKD1.497 2021-09-13
Next Dividend HKD0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 19 --
Total Paid Out HKD2.55 --
Avg. Dividend % Per Year 0.00% --
Score 2.17 --
Div. Sustainability Score 8.21
Div.Growth Potential Score 1.655
Div. Directional Score 4.93 --
Next Divdend (Est)
(2024-07-15)
HKD0 Estimate 0.00 %
Dividend Stability
0.08 Very Bad
Dividend Score
2.17
Pay Frequency
Annually
Yearly Payout
Year Amount Yield

Warning: Undefined variable $stockPricesArray in /home/getagraph/public_html/stock.php on line 1111

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for HKSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
2778.HK Ex Dividend Junior 2023-09-15 Semi-Annually 0 0.00%
1461.HK Ex Dividend Junior 2023-06-20 Sporadic 0 0.00%
0548.HK Ex Dividend Junior 2023-05-19 Annually 0 0.00%
6886.HK Ex Dividend Junior 2023-07-12 Annually 0 0.00%
1985.HK Ex Dividend Knight 2023-08-18 Semi-Annually 0 0.00%
1066.HK Ex Dividend Knight 2023-10-19 Semi-Annually 0 0.00%
0151.HK Ex Dividend Knight 2023-08-24 Semi-Annually 0 0.00%
3393.HK Ex Dividend Knight 2023-05-18 Annually 0 0.00%
1612.HK Ex Dividend Knight 2023-09-05 Annually 0 0.00%
0683.HK Ex Dividend Knight 2023-09-14 Semi-Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.1141.5007.7210.00[0 - 0.5]
returnOnAssetsTTM0.04241.2008.5910.00[0 - 0.3]
returnOnEquityTTM0.06041.500-0.440-0.661[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM2.540.8002.281.820[1 - 3]
quickRatioTTM1.5000.8005.884.71[0.8 - 2.5]
cashRatioTTM0.9391.5005.898.84[0.2 - 2]
debtRatioTTM0.101-1.5008.31-10.00[0 - 0.6]
interestCoverageTTM01.000-1.111-1.111[3 - 30]
operatingCashFlowPerShareTTM0.005962.0010.0010.00[0 - 30]
freeCashFlowPerShareTTM0.004602.0010.0010.00[0 - 20]
debtEquityRatioTTM0.144-1.5009.43-10.00[0 - 2.5]
grossProfitMarginTTM0.6601.0002.332.33[0.2 - 0.8]
operatingProfitMarginTTM0.1911.0008.188.18[0.1 - 0.6]
cashFlowToDebtRatioTTM0.1421.000-0.323-0.323[0.2 - 2]
assetTurnoverTTM0.3710.800-0.859-0.687[0.5 - 2]
Total Score8.21

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM13.031.0008.780[1 - 100]
returnOnEquityTTM0.06042.50-0.283-0.661[0.1 - 1.5]
freeCashFlowPerShareTTM0.004602.0010.0010.00[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM0.005962.0010.0010.00[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM-1.1951.500-10.000[0.5 - 2]
operatingCashFlowSalesRatioTTM0.03881.000-1.5300[0.1 - 0.5]
Total Score1.655

Lansen Pharmaceutical

Lansen Pharmaceutical Holdings Limited, an investment holding company, develops, produces, and sells specialty pharmaceuticals for use in the field of rheumatology and dermatology in the People's Republic of China and internationally. The company operates through Pharmaceuticals, Cosmetics Products, and Healthcare Products segments. It offers Chinese medicine generic drugs; cosmetic products; and healthcare products. The company was founded in 2001 and is headquartered in Ningbo, the People's Republic of China. Lansen Pharmaceutical Holdings Limited is a subsidiary of Cathay International Pharma Manufacture and Distribution (China) Limited.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators